Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Diltiazem Hydrochloride Tablets USP.
Net profit of Indo Euro Indchem rose 800.00% to Rs 0.09 crore in the quarter ended September 2025 as against Rs 0.01 crore during the previous ...
Net Loss of Madhusudan Securities reported to Rs 0.06 crore in the quarter ended September 2025 as against net loss of Rs 0.04 crore during the previous quarte ...
Net loss of Padmalaya Telefilms reported to Rs 0.20 crore in the quarter ended September 2025 as against net profit of Rs 0.07 crore during the previous quarte ...
Sales decline 68.97% to Rs 0.18 crore. Net Loss of Tahmar Enterprises reported to Rs 0.50 crore in the quarter ended September 2025 as against net loss of Rs 0.50 crore during the ...
Sales rise 98.76% to Rs 51.14 crore. Net loss of Madhav Copper reported to Rs 0.20 crore in the quarter ended September 2025 as against net profit of Rs 0.94 crore during the prev ...
Net profit of Steel Exchange India declined 22.43% to Rs 2.11 crore in the quarter ended September 2025 as against Rs 2.72 crore during th ...
Net loss of Pressure Sensitive Systems (India) reported to Rs 0.07 crore in the quarter ended September 2025 as against net profit of Rs 1.19 crore during the ...
Net profit of T & I Global declined 31.66% to Rs 1.77 crore in the quarter ended September 2025 as against Rs 2.59 crore during the previous q ...
Net profit of Akash Agro Industries declined 31.82% to Rs 1.05 crore in the quarter ended September 2025 as against Rs 1.54 crore during the ...
Sales decline 34.58% to Rs 3.86 crore. Net loss of Polycon International reported to Rs 1.02 crore in the quarter ended September 2025. There were no net profit/loss reported duri ...
Sales decline 4.81% to Rs 23.96 crore. Net Loss of Kothari Fermentation & Biochem reported to Rs 3.08 crore in the quarter ended September 2025 as against net loss of Rs 1.75 cror ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results